Biosimulation Market–our new study reveals trends, R&D progress, and predicted revenues
Where is the Biosimulation Market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 120+ page report provides 100+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biosimulation Market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Global Biosimulation Market by Product
• Software
• Services: In-house, Contract
Global Biosimulation Market by Application
• Drug Discovery
• Drug Development
• Others
Global Biosimulation Market by End-use
• Pharmaceutical & Biotechnology Companies
• Academic Research Institutions
• Regulatory Authorities
• CROs
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:
• North America:
• U.S.
• Canada
• Latin America:
• Brazil
• Mexico
• Rest of Latin America
• Europe:
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Asia-Pacific:
• Japan
• China
• India
• Australia
• ASEAN
• Rest of Asia-Pacific
• MEA:
• GCC Countries
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Biosimulation Market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, UK and India, China in particular, will continue to achieve high revenue growth to 2030.
Leading companies and the potential for market growth
Overall world revenue for Biosimulation Market will surpass $xyz billion in 2020, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
To access the data contained in this document please email contactus@visiongain.com
How the Biosimulation Market report helps you
In summary, our 120+ page report provides you with the following knowledge:
• Revenue forecasts to 2030 for Biosimulation Market, with forecasts for Product, Application, End-use, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 17 key national markets – See forecasts for the Biosimulation Market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa.
• Prospects for established firms and those seeking to enter the market– including company profiles of the major companies involved in the Biosimulation Market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Biosimulation Market and leading companies. You will find data, trends and predictions.
Buy our report today Biosimulation Market Report 2020-2030: Forecasts by Product (Software, Services (In-house Services & Contract Services), Application (Drug Discovery, Drug Development, Others), End Use (Pharmaceutical & Biotechnology Companies, Academic Research Institutions, Regulatory Authorities, CROs), and Geography (North America, Latin America, Europe, Asia Pacific, MEA). Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Biosimulation Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Global Biosimulation Market Size and Forecast
2.3. Market Dynamics
2.3.1. Market Drivers
2.3.1.1. Growing adoption of biosimulation software by regulatory bodies
2.3.1.2. Growth in the biologics and biosimilars markets
2.3.1.3. Rising R&D investments in the pharma and biotech industries
2.3.1.4. Technologically advanced QSP systems
2.3.2. Market Restraints/Challenges
2.3.2.1. Lack of Standardization
2.3.3. Opportunities
2.3.3.1. Rise in use of personalized medicine
2.3.3.2. Use of biosimulation solution for pediatric drug development
2.3.4. Global Biosimulation Market: Trends
2.3.5. Mergers and Acquisitions
2.3.6. Entry of New Market Players
2.4. SWOT Analysis
2.5. Porter’s Five Forces Analysis
2.6. PEST Analysis
2.7. COVID-19 Impact Analysis
2.7.1. Qualitative Analysis
2.7.2. Revenues & Forecast (Pre-COVID-19 v.s. Post-COVID-19)
2.7.3. Post COVID-19 Impact Analysis
2.7.3.1. V Shaped Recovery
2.7.3.2. U Shaped Recovery
2.7.3.3. L Shaped Recovery
2.7.3.4. W Shaped Recovery
2.7.4. Impact on Healthcare Industry
2.7.5. Impact of COVID-19 on GDP and Trade
3. Global Biosimulation Market Analysis and Forecast, By Product
3.1. Introduction
3.1.1. Global Biosimulation Market, Annual Growth Rate Comparison by Product
3.1.2. Global Biosimulation Market Share Comparison by Product, (2020, 2025, 2030)
3.2. Global Biosimulation Market Size and Forecast by Product
3.2.1. Software
3.2.2. Services
3.3. Global Biosimulation Attractiveness Index by Product
4. Global Biosimulation Market Analysis and Forecast by Application
4.1. Introduction
4.1.1. Global Biosimulation Market, Annual Growth Rate Comparison by Application
4.1.2. Global Biosimulation Market Share Comparison by Application, (2020, 2025, 2030)
4.2. Global Biosimulation Market Size and Forecast by Application
4.2.1. Drug Discovery
4.2.2. Drug Development
4.2.3. Others
4.3. Global Biosimulation Attractiveness Index by Application
5. Global Biosimulation Market Analysis and Forecast by End-use
5.1. Introduction
5.1.1. Global Biosimulation Market, Annual Growth Rate Comparison by End-use
5.1.2. Global Biosimulation Market Share Comparison by End-use, (2020, 2025, 2030)
5.2. Global Biosimulation Market Size and Forecast by End-use
5.2.1. Pharmaceutical & Biotechnology Companies
5.2.2. Academic Research Institutions
5.2.3. Regulatory Authorities
5.2.4. CROs
5.3. Global Biosimulation Attractiveness Index by End-use
6. Global Biosimulation Market Analysis and Forecast by Region
6.1. Introduction
6.1.1. Global Biosimulation Market, Annual Growth Rate Comparison by Region
6.1.2. Global Biosimulation Market Share Comparison by Region (2020, 2025, 2030)
6.2. Global Biosimulation Market Size and Forecast by Region
6.2.1. North America (U.S., Canada)
6.2.2. Latin America (Brazil, Mexico, Rest of Latin America)
6.2.3. Europe (UK, France, Germany, Italy, Spain, Russia, RoEU)
6.2.4. Asia Pacific (Japan, China, India, ASEAN, Australia, RoAPAC)
6.2.5. MEA (GCC, South Africa, RoMEA)
6.3. Global Biosimulation Market Attractiveness Index by Region
7. North America Biosimulation Market Analysis and Forecast, 2020-2030
7.1. Introduction
7.1.1. North America Biosimulation Market
7.1.2. North America Biosimulation Market, Annual Growth Rate Comparison by Country
7.2. North America Biosimulation Market Size and Forecast by Country
7.2.1. The U.S. Biosimulation Market
7.2.2. Canada Biosimulation Market
7.3. North America Biosimulation Market Size and Forecast by Product
7.4. North America Biosimulation Market Size and Forecast by Application
7.5. North America Biosimulation Market Size and Forecast by End-use
7.6. North America Biosimulation Market Attractiveness Index by Country
8. Latin America Biosimulation Market Analysis and Forecast, 2020-2030
8.1. Introduction
8.1.1. Latin America Biosimulation Market
8.1.2. Latin America Biosimulation Market, Annual Growth Rate Comparison by Country
8.2. Latin America Biosimulation Market Size and Forecast by Country
8.2.1. Brazil Biosimulation Market
8.2.2. Mexico Biosimulation Market
8.2.3. Rest of Latin America Biosimulation Market
8.3. Latin America Biosimulation Market Size and Forecast by Product
8.4. Latin America Biosimulation Market Size and Forecast by Application
8.5. Latin America Biosimulation Market Size and Forecast by End-use
8.6. Latin America Biosimulation Market Attractiveness Index by Country
9. Europe Biosimulation Market Analysis and Forecast, 2020-2030
9.1. Introduction
9.1.1. Europe Biosimulation Market
9.1.2. Europe Biosimulation Market, Annual Growth Rate Comparison by Country
9.2. Europe Biosimulation Market Size and Forecast by Country
9.2.1. U.K. Biosimulation Market
9.2.2. France Biosimulation Market
9.2.3. Germany Biosimulation Market
9.2.4. Italy Biosimulation Market
9.2.5. Spain Biosimulation Market
9.2.6. Russia Biosimulation Market
9.2.7. Rest of Europe Biosimulation Market
9.3. Europe Biosimulation Market Size and Forecast by Product
9.4. Europe Biosimulation Market Size and Forecast by Application
9.5. Europe Biosimulation Market Size and Forecast by End-use
9.6. Europe Biosimulation Market Attractiveness Index by Country
10. Asia Pacific Biosimulation Market Analysis and Forecast, 2020-2030
10.1. Introduction
10.1.1. Asia Pacific Biosimulation Market
10.1.2. Asia Pacific Biosimulation Market, Annual Growth Rate Comparison by Country
10.2. Asia Pacific Biosimulation Market Size and Forecast by Country
10.2.1. China Biosimulation Market
10.2.2. India Biosimulation Market
10.2.3. Australia Biosimulation Market
10.2.4. ASEAN Biosimulation Market
10.2.5. Japan Biosimulation Market
10.2.6. Rest of Asia Pacific Biosimulation Market
10.3. Asia Pacific Biosimulation Market Size and Forecast by Product
10.4. Asia Pacific Biosimulation Market Size and Forecast by Application
10.5. Asia Pacific Biosimulation Market Size and Forecast by End-use
10.6. Asia Pacific Biosimulation Market Attractiveness Index by Country
11. MEA Biosimulation Market Analysis and Forecast, 2020-2030
11.1. Introduction
11.1.1. MEA Biosimulation Market
11.1.2. MEA Biosimulation Market, Annual Growth Rate Comparison by Country
11.2. MEA Biosimulation Market Size and Forecast by Country
11.2.1. GCC Biosimulation Market
11.2.2. South Africa Biosimulation Market
11.2.3. Rest of MEA Biosimulation Market
11.3. MEA Biosimulation Market Size and Forecast by Product
11.4. MEA Biosimulation Market Size and Forecast by Application
11.5. MEA Biosimulation Market Size and Forecast by End-use
11.6. MEA Biosimulation Market Attractiveness Index by Country
12. Leading Companies in the Biosimulation Market
12.1. Competition Dashboard
12.2. Company Share Analysis
12.3. Leading Players
12.4. Advanced Chemistry Development, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance (2015-2019)
12.4.4. Recent Initiatives
12.5. Certara USA, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance (2015-2019)
12.5.4. Recent Initiatives
12.6. Chemical Computing Group, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance (2015-2019)
12.6.4. Recent Initiatives
12.7. Dassault Systems SA
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance (2015-2019)
12.7.4. Recent Initiatives
12.8. Entelos, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance (2015-2019)
12.8.4. Recent Initiatives
12.9. Evidera, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance (2015-2019)
12.9.4. Recent Initiatives
12.10. Genedata AG
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance (2015-2019)
12.10.4. Recent Initiatives
12.11. InhibOx Ltd.
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance (2015-2019)
12.11.4. Recent Initiatives
12.12. Insilico Biotechnology AG
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance (2015-2019)
12.12.4. Recent Initiatives
12.13. LeadInvent Technologies Pvt. Ltd.
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance (2015-2019)
12.13.4. Recent Initiatives
12.14. Leadscope, Inc.
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance (2015-2019)
12.14.4. Recent Initiatives
12.15. Physiomics PLC
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance (2015-2019)
12.15.4. Recent Initiatives
12.16. Schrodinger, Inc.
12.16.1. Company Overview
12.16.2. Product Offerings
12.16.3. Financial Performance (2015-2019)
12.16.4. Recent Initiatives
12.17. Simulation Plus, Inc.
12.17.1. Company Overview
12.17.2. Product Offerings
12.17.3. Financial Performance (2015-2019)
12.17.4. Recent Initiatives
12.18. Rhenovia Pharma Ltd.
12.18.1. Company Overview
12.18.2. Product Offerings
12.18.3. Financial Performance (2015-2019)
12.18.4. Recent Initiatives
13. Conclusion
14. Glossary
15. Appendix
LIST OF TABLES
Table 1 Global Biosimulation Market Size by Region, 2020-2030 (USD Mn, CAGR%)
Table 2 Global Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 3 Global Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 4 Global Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 5 North America: Biosimulation Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 6 North America: Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 7 North America: Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 8 North America: Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 9 U.S. Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 10 U.S. Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 11 U.S. Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 12 Canada Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 13 Canada Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 14 Canada Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 15 Latin America: Biosimulation Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 16 Latin America: Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 17 Latin America: Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 18 Latin America: Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 19 Brazil Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 20 Brazil Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 21 Brazil Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 22 Mexico Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 23 Mexico Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 24 Mexico Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 25 Rest of Latin America Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 26 Rest of Latin America Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 27 Rest of Latin America Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 28 Europe: Biosimulation Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 29 Europe: Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 30 Europe: Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 31 Europe: Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 32 Germany Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 33 Germany Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 34 Germany Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 35 UK Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 36 UK Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 37 UK Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 38 France Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 39 France Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 40 France Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 41 Italy Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 42 Italy Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 43 Italy Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 44 Spain Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 45 Spain Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 46 Spain Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 47 Russia Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 48 Russia Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 49 Russia Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 50 Rest of Europe Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 51 Rest of Europe Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 52 Rest of Europe Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 53 APAC: Biosimulation Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 54 APAC: Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 55 APAC: Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 56 APAC: Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 57 Japan Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 58 Japan Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 59 Japan Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 60 China Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 61 China Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 62 China Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 63 India Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 64 India Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 65 India Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 66 Australia Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 67 Australia Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 68 Australia Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 69 ASEAN Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 70 ASEAN Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 71 ASEAN Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 72 Rest of APAC Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 73 Rest of APAC Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 74 Rest of APAC Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 75 MEA: Biosimulation Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 76 MEA: Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 77 MEA: Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 78 MEA: Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 79 GCC Countries Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 80 GCC Countries Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 81 GCC Countries Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 82 South Africa Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 83 South Africa Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 84 South Africa Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
Table 85 Rest of MEA Biosimulation Market Size by Product, 2020-2030 (USD Mn, CAGR%)
Table 86 Rest of MEA Biosimulation Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 87 Rest of MEA Biosimulation Market Size by End-use, 2020-2030 (USD Mn, CAGR%)
LIST OF FIGURES
Figure 1 Biosimulation Market Segmentation
Figure 2 Drivers, Restraints, Opportunities, and Challenges in the Biosimulation Market
Figure 3 Value Chain Analysis
Figure 4 Porter’s Five Forces Analysis
Figure 5 Global Biosimulation Market by Product (2020-2030)
Figure 6 Global Biosimulation Market by Application (2020-2030)
Figure 7 Global Biosimulation Market by End-use (2020-2030)
Figure 8 Global Biosimulation Market by Region
Figure 9 North America Biosimulation Market Snapshot
Figure 10 U.S. Biosimulation Market, 2020-2030 (USD Mn)
Figure 11 Canada Biosimulation Market, 2020-2030 (USD Mn)
Figure 12 Europe Biosimulation Market Snapshot
Figure 13 Germany Biosimulation Market, 2020-2030 (USD Mn)
Figure 14 France Biosimulation Market, 2020-2030 (USD Mn)
Figure 15 UK Biosimulation Market, 2020-2030 (USD Mn)
Figure 16 Italy Biosimulation Market, 2020-2030 (USD Mn)
Figure 17 Spain Biosimulation Market, 2020-2030 (USD Mn)
Figure 18 Russia Biosimulation Market, 2020-2030 (USD Mn)
Figure 19 APAC Biosimulation Market Snapshot
Figure 20 Japan Biosimulation Market, 2020-2030 (USD Mn)
Figure 21 China Biosimulation Market, 2020-2030 (USD Mn)
Figure 22 India Biosimulation Market, 2020-2030 (USD Mn)
Figure 23 Australia Biosimulation Market, 2020-2030 (USD Mn)
Figure 24 ASEAN Biosimulation Market, 2020-2030 (USD Mn)
Figure 25 Latin America Biosimulation Market Snapshot
Figure 26 Brazil Biosimulation Market, 2020-2030 (USD Mn)
Figure 27 Mexico Biosimulation Market, 2020-2030 (USD Mn)
Figure 28 MEA Biosimulation Market Snapshot
Figure 29 GCC Countries Biosimulation Market, 2020-2030 (USD Mn)
Figure 30 South Africa Biosimulation Market, 2020-2030 (USD Mn)
Figure 31 Company Market Share Analysis
Figure 32 Advanced Chemistry Development, Inc. Financial Snapshot
Figure 33 Certara USA, Inc. Financial Snapshot
Figure 34 Chemical Computing Group, Inc. Financial Snapshot
Figure 35 Dassault Systems SA Financial Snapshot
Figure 36 Entelos, Inc. Financial Snapshot
Figure 37 Evidera, Inc. Financial Snapshot
Figure 38 Genedata AG Financial Snapshot
Figure 39 InhibOx Ltd. Financial Snapshot
Figure 40 Insilico Biotechnology AG Financial Snapshot
Figure 41 LeadInvent Technologies Pvt. Ltd. Financial Snapshot
Figure 42 Leadscope, Inc. Financial Snapshot
Figure 43 Physiomics PLC Financial Snapshot
Figure 44 Schrodinger, Inc. Financial Snapshot
Figure 45 Simulation Plus, Inc. Financial Snapshot
Figure 46 Rhenovia Pharma Ltd. Financial Snapshot
